DAVENPORT & Co LLC

Position in ROIV — Roivant Sciences Ltd.

CIK 887777 RICHMOND, VA

Position in ROIV

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$481,304

+$187,684 QoQ

Shares Held

13,600

+28.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#287

of 494 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DAVENPORT & Co LLC holds $137,698,050 across 19 Biotechnology names. ROIV ranks #10 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	207,108	$102,876,756
2	IONS	Ionis Pharmaceuticals Inc	283,960	$22,515,188
3	CGTX	Cognition Therapeutics Inc	4,259,511	$4,898,437
4	GMAB	Genmab A/S	42,544	$1,168,683
5	MGTX	MeiraGTx Holdings plc	72,370	$977,718
6	ARGX	Argenx SE	929	$861,898
7	JAZZ	Jazz Pharmaceuticals plc	3,190	$768,694
8	RARE	Ultragenyx Pharmaceutical Inc.	19,500	$651,105

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$481,304	13,600	+28.3%	Shares	Sole	2026-07-13
2026-03-31	$293,620	10,600	+6.0%	Shares	Sole	2026-04-15
2025-09-30	$151,300	10,000	-17.4%	Shares	Sole	2025-10-15
2025-06-30	$136,367	12,100	-44.2%	Shares	Sole	2025-07-22
2025-03-31	$218,953	21,700	-86.4%	Shares	Sole	2025-04-28
2024-12-31	$1,894,456	160,140	-38.7%	Shares	Sole	2025-01-24
2024-09-30	$3,017,017	261,440	-10.6%	Shares	Sole	2024-10-24
2024-06-30	$3,089,611	292,300	-4.7%	Shares	Sole	2024-08-06
2024-03-31	$3,232,618	306,700	+8.3%	Shares	Sole	2024-05-03
2023-12-31	$3,178,988	283,080	+1.8%	Shares	Sole	2024-01-23
2023-09-30	$3,246,806	277,980	+9.2%	Shares	Sole	2023-10-17
2023-06-30	$2,566,166	254,580	+22.9%	Shares	Sole	2023-07-20
2023-03-31	$1,528,398	207,100	—	Shares	Sole	2023-04-27
No filing history on record for this holder in this stock.